CORCEPT THERAPEUTICS INC Retained Earnings
CORCEPT THERAPEUTICS INC (CORT) had Retained Earnings of $654.61 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-29
- 2026-06-30: Retained Earnings (Accumulated Deficit) $654.61M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $611.63M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $643.39M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $619.10M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | $654.61M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $611.63M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $643.39M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $619.10M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $599.43M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $564.28M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $543.74M 10-K · filed 2026-02-24 |
| 2024-09-30 | $512.99M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $465.78M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $430.29M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $402.53M 10-K · filed 2025-02-26 |
| 2023-09-30 | $371.17M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $339.79M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $312.26M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $296.39M 10-K · filed 2024-02-15 |
| 2022-09-30 | $279.79M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $245.18M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $217.76M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $194.97M 10-K · filed 2023-02-28 |
| 2021-09-30 | $162.91M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $132.44M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $105.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $82.46M 10-K · filed 2022-02-15 |
| 2020-09-30 | $56.46M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $34.84M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $6.51M 10-Q · filed 2020-05-04 |
| 2019-12-31 | -$23.55M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$52.94M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$79.28M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$99.46M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$117.74M 10-K · filed 2020-02-24 |
| 2018-09-30 | -$139.74M 10-Q · filed 2018-11-02 |
| 2018-06-30 | -$157.49M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$175.69M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$193.15M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$291.48M 10-Q · filed 2017-11-03 |
| 2017-06-30 | -$305.23M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$317.88M 10-Q · filed 2017-05-02 |
| 2016-12-31 | -$322.27M 10-K · filed 2018-02-28 |
| 2016-09-30 | -$326.87M 10-Q · filed 2016-11-02 |
| 2016-06-30 | -$329.45M 10-Q · filed 2016-08-03 |
| 2016-03-31 | -$330.43M 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$330.41M 10-K · filed 2017-03-06 |
| 2015-09-30 | -$331.37M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$330.77M 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$328.83M 10-Q · filed 2015-05-08 |
| 2014-12-31 | -$324.00M 10-K · filed 2016-03-10 |
| 2014-09-30 | -$320.11M 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$314.10M 10-Q · filed 2014-08-08 |
| 2014-03-31 | -$306.55M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$292.62M 10-K · filed 2015-03-13 |
| 2013-09-30 | -$281.49M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$270.59M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$258.69M 10-Q · filed 2013-05-08 |
| 2012-12-31 | -$246.61M 10-K · filed 2014-03-14 |
| 2012-03-31 | -$219.59M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$208.56M 10-Q · filed 2012-05-10 |
| 2011-09-30 | -$198.62M 10-Q · filed 2011-11-08 |
| 2011-06-30 | -$192.19M 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$176.20M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |